{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:18:31Z","timestamp":1794673111318,"version":"4.9.1"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,28]]},"DOI":"10.1097\/01.aids.0000433236.55937.cb","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T19:54:14Z","timestamp":1375818854000},"page":"2933-2942","source":"Crossref","is-referenced-by-count":64,"title":["Contribution of HIV infection to mortality among cancer patients in Uganda"],"prefix":"10.1097","volume":"27","author":[{"given":"Anna E.","family":"Coghill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly A.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Madeleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Mutyaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Okuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Wabinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Orem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Casper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","article-title":"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.","volume":"24","author":"Ray","year":"2010","journal-title":"AIDS"},{"key":"R2-12-20210130","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/j.1365-3156.2012.02841.x","article-title":"The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999-2009.","volume":"17","author":"Kasamba","year":"2012","journal-title":"Trop Med Int Health"},{"key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-155-4-201108160-00358","article-title":"Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.","volume":"155","author":"Mills","year":"2011","journal-title":"Ann Intern Med"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/94.16.1204","article-title":"Trends in Kaposis sarcoma and non-Hodgkins lymphoma incidence in the United States from 1973 through 1998.","volume":"94","author":"Eltom","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200304150-00010","article-title":"Immune deficiency and risk for malignancy among persons with AIDS.","volume":"32","author":"Mbulaiteye","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinternmed.2010.253","article-title":"Spectrum of cancer risk late after AIDS onset in the United States.","volume":"170","author":"Simard","year":"2010","journal-title":"Arch Intern Med"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0b013e3181b033ab","article-title":"Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.","volume":"52","author":"Bedimo","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-12-20210130","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002.","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"R10-12-20210130","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.","volume":"27","author":"Powles","year":"2009","journal-title":"J Clin Oncol"},{"key":"R11-12-20210130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.","volume":"52","author":"Shiels","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-med-050409-103711","article-title":"The increasing burden of HIV-associated malignancies in resource-limited regions.","volume":"62","author":"Casper","year":"2011","journal-title":"Annu Rev Med"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.24838","article-title":"Changing cancer incidence in Kampala, Uganda, 1991-2006.","volume":"126","author":"Parkin","year":"2010","journal-title":"Int J Cancer"},{"key":"R14-12-20210130","first-page":"1585","article-title":"Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997.","volume":"82","author":"Wabinga","year":"2000","journal-title":"Br J Cancer"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ijc.21443","article-title":"Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study.","volume":"118","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1097\/00002030-199912240-00010","article-title":"AIDS-related cancers in Africa: maturation of the epidemic in Uganda.","volume":"13","author":"Parkin","year":"1999","journal-title":"AIDS"},{"key":"R18-12-20210130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/CCO.0b013e328355e14b","article-title":"Impact of antiretroviral therapy on the incidence of Kaposi sarcoma in resource-rich and resource-limited settings.","volume":"24","author":"Semeere","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1086\/424883","article-title":"Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.","volume":"39","author":"Bedimo","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS.","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS"},{"key":"R22-12-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States.","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"R23-12-20210130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/ijc.28125","article-title":"Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence.","volume":"133","author":"Chaabna","year":"2013","journal-title":"Int J Cancer"},{"key":"R24-12-20210130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/QAI.0b013e31820c011a","article-title":"Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.","volume":"56","author":"Bateganya","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-12-20210130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1008966225984","article-title":"Completeness in an African cancer registry.","volume":"12","author":"Parkin","year":"2001","journal-title":"Cancer Causes Control"},{"key":"R27-12-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjc.6601034","article-title":"Survival of cervix cancer patients in Kampala, Uganda: 1995-1997.","volume":"89","author":"Wabinga","year":"2003","journal-title":"Br J Cancer"},{"key":"R28-12-20210130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.qai.0000164033.02947.e3","article-title":"Survival after cancer diagnosis in persons with AIDS.","volume":"39","author":"Biggar","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-12-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ijc.2910600209","article-title":"Cancer risk after renal transplantation in the Nordic countries, 1964-1986.","volume":"60","author":"Birkeland","year":"1995","journal-title":"Int J Cancer"},{"key":"R31-12-20210130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation.","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"key":"R32-12-20210130","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation.","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"R33-12-20210130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2009-02-202507","article-title":"Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.","volume":"114","author":"van Leeuwen","year":"2009","journal-title":"Blood"},{"key":"R34-12-20210130","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients.","volume":"306","author":"Engels","year":"2011","journal-title":"J Am Med Assoc"},{"key":"R35-12-20210130","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","article-title":"HIV infection, immunodeficiency, viral replication, and the risk of cancer.","volume":"20","author":"Silverberg","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R36-12-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIVAIDS compared with immunosuppressed transplant recipients: a meta-analysis.","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"R37-12-20210130","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.transproceed.2006.10.144","article-title":"Immunosuppression and cancer: a comparison of risks in recipients of organ transplants and in HIV-positive individuals.","volume":"38","author":"Busnach","year":"2006","journal-title":"Transplant Proc"},{"key":"R39-12-20210130","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ejca.2007.07.015","article-title":"Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.","volume":"43","author":"Serraino","year":"2007","journal-title":"Eur J Cancer"},{"key":"R40-12-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/COH.0b013e328319bcd1","article-title":"What types of cancers are associated with immune suppression in HIV Lessons from solid organ transplant recipients.","volume":"4","author":"Vajdic","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"R41-12-20210130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI119315","article-title":"Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkins lymphoma.","volume":"99","author":"Kersten","year":"1997","journal-title":"J Clin Invest"},{"key":"R42-12-20210130","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2005-01-0432","article-title":"Loss of EBNA1-specific memory CD4 and CD8 T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.","volume":"106","author":"Piriou","year":"2005","journal-title":"Blood"},{"key":"R43-12-20210130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/blood.V98.1.146","article-title":"Dysfunctional Epstein-Barr virus (EBV)-specific CD8() T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.","volume":"98","author":"van Baarle","year":"2001","journal-title":"Blood"},{"key":"R46-12-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences.","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"R47-12-20210130","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.1002000","article-title":"CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.","volume":"186","author":"Catalfamo","year":"2011","journal-title":"J Immunol"},{"key":"R48-12-20210130","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1128\/JVI.75.24.11983-11991.2001","article-title":"Analysis of total human immunodeficiency virus (HIV)-specific CD4() and CD8() T-cell responses: relationship to viral load in untreated HIV infection.","volume":"75","author":"Betts","year":"2001","journal-title":"J Virol"},{"key":"R49-12-20210130","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1073\/pnas.250472097","article-title":"Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4 and CD8 T cell turnover in HIV-infected patients.","volume":"97","author":"Lempicki","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-12-20210130","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0506857102","article-title":"Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.","volume":"102","author":"Popovic","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R51-12-20210130","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.1128\/JVI.00387-10","article-title":"HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.","volume":"84","author":"Mens","year":"2010","journal-title":"J Virol"},{"key":"R52-12-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2004.10.003","article-title":"Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system.","volume":"97","author":"van Baarle","year":"2005","journal-title":"Immunol Lett"},{"key":"R53-12-20210130","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1371\/journal.pbio.0020020","article-title":"Immune activation and CD8 T-cell differentiation towards senescence in HIV-1 infection.","volume":"2","author":"Papagno","year":"2004","journal-title":"PLoS Biol"},{"key":"R54-12-20210130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0167-5699(97)01079-7","article-title":"Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion.","volume":"18","author":"Effros","year":"1997","journal-title":"Immunol Today"},{"key":"R55-12-20210130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5483\/BMBRep.2011.44.4.217","article-title":"Mechanism of T cell exhaustion in a chronic environment.","volume":"44","author":"Jin","year":"2011","journal-title":"BMB Rep"},{"key":"R56-12-20210130","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R57-12-20210130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"key":"R58-12-20210130","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma.","volume":"192","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"R59-12-20210130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape.","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"R60-12-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(06)90001-7","article-title":"Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.","volume":"90","author":"Smyth","year":"2006","journal-title":"Adv Immunol"},{"key":"R61-12-20210130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"R62-12-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes.","volume":"12","author":"Boon","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"R63-12-20210130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jlb.60.3.296","article-title":"Human tumor antigens recognized by T lymphocytes: implications for cancer therapy.","volume":"60","author":"Wang","year":"1996","journal-title":"J Leukoc Biol"},{"key":"R64-12-20210130","first-page":"3491","article-title":"CD8 T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res"},{"key":"R65-12-20210130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored.","volume":"29","author":"Pages","year":"2010","journal-title":"Oncogene"},{"key":"R66-12-20210130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2249.2010.04311.x","article-title":"Association of CD8() T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.","volume":"164","author":"Tsuchikawa","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R67-12-20210130","first-page":"3932","article-title":"Prognostic significance of activated CD8() T cell infiltrations within esophageal carcinomas.","volume":"61","author":"Schumacher","year":"2001","journal-title":"Cancer Res"},{"key":"R68-12-20210130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV Infection, Inflammation, Immunosenescence, and Aging.","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"R69-12-20210130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1570162054368057","article-title":"HIV and inflammation.","volume":"3","author":"Decrion","year":"2005","journal-title":"Curr HIV Res"},{"key":"R71-12-20210130","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"R73-12-20210130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archinte.166.1.64","article-title":"C-reactive protein is a marker for human immunodeficiency virus disease progression.","volume":"166","author":"Lau","year":"2006","journal-title":"Arch Intern Med"},{"key":"R74-12-20210130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow.","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"R75-12-20210130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer.","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"R76-12-20210130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer.","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"R77-12-20210130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.aids.0000433236.55937.cb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:47:09Z","timestamp":1620935229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201311280-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":69,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000433236.55937.cb","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,28]]}}}